Day: September 25, 2024

Please see attached Company Announcement no 9 – 2024AttachmentCompany Announce no 9 – 2024

Amsterdam, September 25, 2024 — Virtune, a regulated Swedish digital asset manager and issuer of crypto exchange-traded products (ETPs) headquartered in Stockholm, is expanding to the Netherlands with the listing of Virtune Staked Solana ETP on Euronext Amsterdam. With strong growth and steady inflows in the Nordic region, driven by increasing interest and acceptance of crypto assets, this expansion marks a strategic milestone for Virtune. Since its inception in May 2023, Virtune has rapidly grown in the Nordics, listing a total of 12 products and reaching over 31,000 investors in just over a year. Key success factors have included a focus on education, a transparent market strategy, and the company’s regulated status. This expansion not only meets the growing investor interest but also strengthens Virtune’s market presence...

TOKYO, Sept. 25, 2024 (GLOBE NEWSWIRE) — Leading semiconductor test equipment supplier Advantest Corporation (TSE: 6857) today announced that it has been awarded Qualcomm’s 2024 Supplier of the Year – Test Equipment & Hardware award at the Qualcomm Supplier Summit in San Diego. The Qualcomm Supplier Summit celebrates and recognizes the company’s outstanding supplier partners across categories. Supplier partners help support Qualcomm’s diversification strategy as the company executes on the opportunities ahead across automotive, compute, XR, industrial IoT and more. “We are thrilled to award Advantest with the 2024 Supplier of the Year award in the Test Equipment & Hardware category,” said Kee K. Chang, SVP, Chief Procurement Officer, Qualcomm Technologies, Inc. “We utilize Advantest technology across key parts of...

As previously communicated via the stock exchange announcement of 28 June 2024, Veiko Räim’s mandate as a Member of the Management Board and CFO of Enefit Green expired on 24 September 2024. The process of selecting a new board member is ongoing. Until the new CEO Juhan Aguraiuja takes office on 14 October 2024, the Management Board of Enefit Green will continue to work with two members on a temporary basis. In addition to interim CEO Andres Maasing, the Management Board also includes Innar Kaasik, who is responsible for production and asset management.Further information: Sven Kunsing Head of Finance Communication investor@enefitgreen.ee https://enefitgreen.ee/en/investorile/ Enefit Green is one of the leading renewable energy producers in the Baltic Sea area. The Company operates wind farms in Estonia and Lithuania, waste-to-energy...

EXPLORATION DRILLING UNDERWAY, BIHOR SUD PROJECT, ROMANIA – Diamond Drilling in gallery G7 targeting Cobalt-Nickel-Gold mineralization – Mapping of significant Zinc-Lead-Silver-Copper mineralization in gallery G2 – Drilling to follow in G2 after G7 – Focus is on defining a large-scale, potentially mineable body of mineralization Vancouver, September 24, 2024 – Leading Edge Materials Corp. (“Leading Edge Materials” or the “Company”) (TSXV: LEM) (Nasdaq First North: LEMSE) (OTCQB: LEMIF) (FRA: 7FL) is pleased to announce that exploration diamond drilling is underway at the Company’s Bihor Sud Project in Romania.   The primary objective is to identify a large-scale, potentially mineable body of mineralization. Early findings have already highlighted the strong potential for discovering significant polymetallic mineralized...

23, Place des Carmes-Déchaux – 63000 CLERMONT-FERRAND Information about securities repurchasing programRegulated informationIssuer social denomination: Michelin – LEI 549300SOSI58J6VIW052 Types of securities: ordinary shares – Code ISIN FR 0000121261Date : September 25th, 2024Issuer Name Issuer code Transaction date ISIN Code Daily total volume (in number of actions) Daily weighted average price of shares acquired PlatformCompagnie Générale des Etablissements Michelin 549300SOSI58J6VIW052 25.09.2024 FR001400AJ45 171 516 35,0757 euros Gré à gréCompagnie Générale des Etablissements Michelin 549300SOSI58J6VIW052 25.09.2024 FR001400AJ45 51 455 35,0756 euros Gré à gréIssuer Name Issuer code PSIName Issuer Code Transaction date   ISIN Code Unit Price Currency Quantity bought Platform Transaction reference number Buyback...

THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONSResults for the Six Months to 30 June 2024 driven by 4.3% Uplift From Private Valuations 25 September 2024 NB Private Equity Partners (NBPE), the $1.3bn1 listed private equity investment company managed by Neuberger Berman, today announces its results for the six months to 30 June 2024. Highlights from six months to 30 June 2024Net Assets of $1.3 bn – NAV per share of $27.87 (£22.05) a return of 1.0% in the six months Performance driven by 4.3% increase in private company valuations (ex-FX), which have been partially offset by continued volatility in quoted holdings and foreign exchange headwinds Positive operating performance continues...

Press releaseParis, 25 September 2024 Orange intends to voluntarily delist from the NYSE, deregister with the SEC, and launch a consent solicitation in relation to certain outstanding notes Following the decision taken by the Board of Directors on 24 September Orange announces today its intention to voluntarily delist its American Depositary Shares (“ADR”) from the New York Stock Exchange (“NYSE”) and voluntarily deregister with the U.S. Securities and Exchange Commission (“SEC”). Once the delisting is effective, Orange intends to maintain its American Depositary Receipt (“ADR”) program, which will enable investors to retain their ADRs and facilitate trading on the U.S. Over-The-Counter (“OTC”) market. The decision to voluntarily delist from the NYSE and to deregister from the SEC was made after careful consideration by the Board of Directors,...

SHANGHAI, Sept. 24, 2024 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, and its wholly-owned subsidiary, TopAlliance Biosciences Inc. (TopAlliance Biosciences), announce that the European Commission (EC) has approved toripalimab (European trade name: LOQTORZI®) for the treatment of two indications:Toripalimab in combination with cisplatin and gemcitabine for the first-line treatment of adult patients with recurrent, not amenable to surgery or radiotherapy, or metastatic nasopharyngeal carcinoma (NPC); Toripalimab in combination with cisplatin and paclitaxel for the first-line treatment of adult patients with unresectable advanced, recurrent,...